EQS Group-Media / 2020-05-26 / 19:30
*Media Release*
*Medacta Announces CE Marking for Multiple Sports Medicine Products and
First Surgeries Utilizing MectaTap TI Anchor and FastShuttle Suture Passer*
_CASTEL SAN PIETRO_, _26 May 2020 _- Medacta announced today the first
surgeries utilizing its MectaTap TI Anchor and FastShuttle Suture Passer.
Medacta's Sports Medicine business unit has also obtained CE marking for
various devices for hip, knee and shoulder arthroscopy.
*First Surgeries Utilizing MectaTap TI Anchor and FastShuttle Suture Passer*
During the first two weeks in May, Wesley Cox, M.D., from the University of
Arkansas Orthopaedics and Sports Medicine, in Fayetteville, AR (USA)
performed several rotator cuff surgeries using the Medacta MectaTap Ti Cuff
Anchor for the first time worldwide. He also used the newly available
FastShuttle Suture Passer for shuttling sutures through the rotator cuff.
"The surgery went perfectly," said Dr. Cox. "As expected, the anchor had
phenomenal hold within the bone allowing very solid fixation, and the
instruments couldn't have performed better for my patient. We will be using
it in all our rotator cuff repairs moving forward."
*CE Marking for Multiple Sports Medicine Products*
In recent weeks, Medacta's Sports Medicine business unit has also obtained
CE marking for multiple devices:
- *MectaFix Continuous Loop* and *Mectascrew B* absorbable interference
screw for ACL knee reconstructions
- *PowerKnot High Strength Suture*, a strong USP#2 suture with reliable knot
tying features
- *FastShuttle Suture Passer* to facilitate passing and retrieving sutures
in rotator cuff repairs
- *FastShuttle Suture Passer cc* for hip capsular closure
- *MectaScope* for hip and shoulder arthroscopy
Medacta's Sports Medicine product portfolio continues to grow, and many
exciting products are expected to be launched in the coming months.
For more information on Medacta Sports Medicine please visit
sportsmed.medacta.com [1].
*Contact*
Medacta International SA
Gianluca Olgiati
Senior Director Global Marketing
Phone: +41 91 696 60 60
media@medacta.ch
*About Medacta*
Medacta is an international company specialized in the design and production
of innovative orthopaedic products and the development of accompanying
surgical techniques for joint replacement, spine surgery, and sports
medicine. Established in 1999 in Switzerland, Medacta's products and
surgical techniques are characterized by innovation. Medacta is a pioneer in
developing new offerings on the basis of minimally invasive surgical
techniques, in particular its Anterior Minimally Invasive Surgery (AMIS)
technique for hip replacements. Medacta has leveraged its orthopaedic
expertise and comprehensive understanding of the human body to develop the
sophisticated MySolutions technology, which offers surgeons highly
personalized pre-operative planning and implant placement methodologies by
creating advanced personalized kinematic models and 3D planning tools for
use in hip, knee, shoulder and spine procedures.
Issuer: Medacta Group SA
Key word(s): Research/Technology
End of Corporate News
Language: English
Company: Medacta Group SA
Strada Regina
6874 Castel San Pietro
Switzerland
Phone: +41 91 696 6060
E-mail: info@medacta.ch, investor.relations@medacta.ch
Internet: www.medacta.com
ISIN: CH0468525222
Listed: SIX Swiss Exchange
EQS News ID: 1055851
End of News EQS Group Media
1055851 2020-05-26
1: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=0c1738d357bc966e3dc5040ac2977055&application_id=1055851&site_id=vwd&application_name=news
(END) Dow Jones Newswires
May 26, 2020 13:30 ET (17:30 GMT)
